We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Master Gene Found for Intellectual Disability and Epilepsy

By Biotechdaily staff writers
Posted on 22 May 2002
For the first time, researchers have identified a major gene that is responsible for intellectual disability and epilepsy, which often occur together and frequently have genetic causes. More...
Previously nine other epilepsy-causing genes had been identified, belonging predominantly to a specific group called ‘ion channels,' but they have nothing to do with intellectual disability.

"This gene is found on the X-chromosome and is one of probably 100 genes on that chromosome, which when mutated, can cause intellectual disability. The really novel aspect to this gene is its involvement in epilepsy as well as in intellectual disability,” said Dr. Jozef Gecz, from the Department of Cytogenetics and Molecular Genetics of the Women's and Children's Hospital (Adelaide, Australia).

Dr. Gecz explained that the new gene is different, being more of a master gene that controls how, where, and when other genes work and thus contributing to the normal cognitive function of the human brain. "It will be very interesting to know the identity of the genes that are under control of this master gene, as they may potentially be involved in either epilepsy, intellectual disability, or both,” added Dr. Gecz, who led a team of 17 researchers from six collaborating countries. The study was published on March 11, 2002, on the Nature Genetics website.

The researchers studied genetic material from nine families from different parts of the world. They found that the same mutations in the gene gave rise to epilepsy, including early childhood epilepsy and other types of seizures, dystonia, and intellectual disability. It is not yet known why this should occur. Families and isolated cases with ‘nonspecific' intellectual disability may be the main beneficiaries of the identification of this gene. If substantiated by further experiments, the research may speed diagnosis of the disorder that until now was only revealed by delayed development and intellectual impairment.




Related Links:
Women's and Children's Hospital

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Urine Analyzer
respons® UDS100
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.